Our company goal is preventing blindness for the estimated 80 million people who will suffer from glaucoma by 2020.

Our product, under development, addresses an unmet need by rendering accessible a continuous measurement of the intraocular pressure.

The key benefits for the medical professional and the patient is to increase the quality and relevance of diagnostic and treatment of gaucoma.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.